IndieBio -Designing Science

Steve Blank, Entrepreneur and Founder of the Lean Startup movement featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

David Eagleman, Neuroscientist, Author & Founder of NeoSensorgy featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Tim Lu of Senti Biosciences featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio